Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析

◆英語タイトル:Mayne Pharma Group Ltd (MYX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14888
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, doryx capsules, magnoplasm, astrix capsules and tablets, and lozanoc and itragerm capsules. It offers services such as analytical development, product development, contract manufacturing, logistics, and formulation development, others. Mayne Pharma offers its products in the dosage forms of tablets, capsules, powders, liquids, and creams. The company operates manufacturing facilities in Australia and the US. Mayne Pharma is headquartered in Adelaide, South Australia, Australia.

Mayne Pharma Group Ltd Key Recent Developments

Feb 22,2019: Mayne Pharma reports stronger 1HFY19 results
Aug 24,2018: Mayne Pharma reports FY 18 result s underpinned by a significantly stronger second half
Jun 28,2018: Mayne Pharma Names Patrick Blake As New Director
May 30,2018: Mayne Pharma Announces New Board Director
Apr 18,2018: Mayne Pharma Opens New Solid Oral-dose Manufacturing Facility In US

This comprehensive SWOT profile of Mayne Pharma Group Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mayne Pharma Group Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mayne Pharma Group Ltd – Key Information
Mayne Pharma Group Ltd – Overview
Mayne Pharma Group Ltd – Key Employees
Mayne Pharma Group Ltd – Key Employee Biographies
Mayne Pharma Group Ltd – Key Operational Heads
Mayne Pharma Group Ltd – Major Products and Services
Mayne Pharma Group Ltd – History
Mayne Pharma Group Ltd – Company Statement
Mayne Pharma Group Ltd – Locations And Subsidiaries
Mayne Pharma Group Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mayne Pharma Group Ltd – Business Description
Mayne Pharma Group Ltd – Corporate Strategy
Mayne Pharma Group Ltd – SWOT Analysis
SWOT Analysis – Overview
Mayne Pharma Group Ltd – Strengths
Mayne Pharma Group Ltd – Weaknesses
Mayne Pharma Group Ltd – Opportunities
Mayne Pharma Group Ltd – Threats
Mayne Pharma Group Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Mayne Pharma Group Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mayne Pharma Group Ltd, Key Information
Mayne Pharma Group Ltd, Key Ratios
Mayne Pharma Group Ltd, Share Data
Mayne Pharma Group Ltd, Major Products and Services
Mayne Pharma Group Ltd, History
Mayne Pharma Group Ltd, Key Employees
Mayne Pharma Group Ltd, Key Employee Biographies
Mayne Pharma Group Ltd, Key Operational Heads
Mayne Pharma Group Ltd, Other Locations
Mayne Pharma Group Ltd, Subsidiaries
Mayne Pharma Group Ltd, Key Manufacturing facilities
Mayne Pharma Group Ltd, Key Competitors
Mayne Pharma Group Ltd, SWOT Analysis
Mayne Pharma Group Ltd, Ratios based on current share price
Mayne Pharma Group Ltd, Annual Ratios
Mayne Pharma Group Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Mayne Pharma Group Ltd, Performance Chart
Mayne Pharma Group Ltd, Ratio Charts

★海外企業調査レポート[Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Datang International Power Generation Co Ltd (991):電力:M&Aディール及び事業提携情報
    Summary Datang International Power Generation Company Limited (Datang Power), a subsidiary of China Datang Corporation, is an independent power generation company. It develops power plants; produces and distributes electricity; and sells heat. The company generates electricity from coal-fired genera …
  • RWE AG (RWE)-石油・ガス分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • International Business Machines Corporation:企業のM&A・事業提携・投資動向
    International Business Machines Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's International Business Machines Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, det …
  • Advocate Health Care:企業の戦略的SWOT分析
    Advocate Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Localiza Rent A Car SA:企業の戦略・SWOT・財務情報
    Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report Summary Localiza Rent A Car SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • TxCell SA (TXCL):製薬・医療:M&Aディール及び事業提携情報
    Summary Txcell SA (Txcell) is a biotechnology company that develops and innovates cell-based immunotherapy utilizing antigen specific regulatory T-cells. The company provides pipeline products such as car-treg transplantation, car-treg lupus, car-treg dermatology, ovasave and col-treg. It offers pro …
  • Central Electricity Generating Co:発電所・企業SWOT分析
    Central Electricity Generating Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises br …
  • Detour Gold Corp:企業の戦略・SWOT・財務分析
    Detour Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Detour Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hospitality Properties Trust:企業のM&A・事業提携・投資動向
    Hospitality Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hospitality Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Ridley USA Inc:企業の戦略的SWOT分析
    Ridley USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • Seven Generations Energy Ltd (VII):企業の財務・戦略的SWOT分析
    Seven Generations Energy Ltd (VII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • University of Toronto-製薬・医療分野:企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • Snam S.p.A. (SRG):電力:M&Aディール及び事業提携情報
    Summary Snam S.p.A. (Snam) is an integrated midstream energy company. The company, through its subsidiaries, carries out the regasification, transportation, storage and supply of natural gas. Snam Rete Gas, its subsidiary, transports natural gas; GNL Italia conducts regasification; and Stogit stores …
  • Canadian Tire Corporation, Limited:戦略・SWOT・企業財務分析
    Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report Summary Canadian Tire Corporation, Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • One Way Liver SL:医療機器:M&Aディール及び事業提携情報
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that develops, discovers, and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver that is a serum based test used for steatosis and NASH diagno …
  • SpectraScience Inc (SCIE):企業の製品パイプライン分析2018
    Summary SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆